Emergent BioSolutions Inc (EBS)
9.97
-0.92
(-8.45%)
USD |
NYSE |
Nov 13, 16:00
9.97
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Net Income (TTM): -587.00M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -587.00M |
| March 31, 2024 | -565.30M |
| December 31, 2023 | -760.50M |
| September 30, 2023 | -778.00M |
| June 30, 2023 | -601.70M |
| March 31, 2023 | -396.70M |
| December 31, 2022 | -214.20M |
| September 30, 2022 | 30.70M |
| June 30, 2022 | 85.10M |
| March 31, 2022 | 146.10M |
| December 31, 2021 | 219.50M |
| September 30, 2021 | 227.70M |
| June 30, 2021 | 299.90M |
| March 31, 2021 | 388.00M |
| December 31, 2020 | 305.80M |
| September 30, 2020 | 166.60M |
| June 30, 2020 | 170.30M |
| March 31, 2020 | 68.10M |
| December 31, 2019 | 54.60M |
| September 30, 2019 | 4.20M |
| June 30, 2019 | -18.10M |
| March 31, 2019 | 41.50M |
| December 31, 2018 | 62.60M |
| September 30, 2018 | 100.05M |
| June 30, 2018 | 112.70M |
| Date | Value |
|---|---|
| March 31, 2018 | 67.22M |
| December 31, 2017 | 82.60M |
| September 30, 2017 | 86.07M |
| June 30, 2017 | 73.86M |
| March 31, 2017 | 58.29M |
| December 31, 2016 | 51.80M |
| September 30, 2016 | 47.73M |
| June 30, 2016 | 63.33M |
| March 31, 2016 | 88.38M |
| December 31, 2015 | 62.87M |
| September 30, 2015 | 59.64M |
| June 30, 2015 | 44.53M |
| March 31, 2015 | 35.46M |
| December 31, 2014 | 36.74M |
| September 30, 2014 | 21.85M |
| June 30, 2014 | 13.51M |
| March 31, 2014 | 18.96M |
| December 31, 2013 | 31.14M |
| September 30, 2013 | 32.02M |
| June 30, 2013 | 25.15M |
| March 31, 2013 | 22.29M |
| December 31, 2012 | 23.53M |
| September 30, 2012 | 36.08M |
| June 30, 2012 | 31.01M |
| March 31, 2012 | 37.59M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-778.00M
Minimum
Sep 2023
388.00M
Maximum
Mar 2021
-91.63M
Average
68.10M
Median
Mar 2020
Net Income (TTM) Benchmarks
| Geovax Labs Inc | -26.92M |
| Tonix Pharmaceuticals Holding Corp | -149.01M |
| Abbott Laboratories | 5.767B |
| SIGA Technologies Inc | 83.97M |
| Chimerix Inc | -84.70M |